The cost of immunotherapy for lung cancer in Thailand typically ranges from $25,000 / ฿850,000 to $45,000 / ฿1,530,000. Prices vary depending on the type of immunotherapy drug (such as pembrolizumab or nivolumab), the number of treatment cycles, and the hospital’s reputation. In the United States, the average cost is $90,000 / ฿3,060,000 (per ASCO). That means immunotherapy for lung cancer in Thailand is about 61% less than in the U.S.
Thai hospitals generally include the initial oncology consultation, diagnostic tests (CT scans, bloodwork), medication administration, and follow-up visits in the package price. In the U.S., drug costs, infusion fees, and specialist visits are often billed separately. Always confirm with the clinic which services, medications, and follow-up care are included in your quoted price.